Mold-Tek Packaging Q1 FY27 Earnings Call Transcript Released
Mold-Tek Packaging's Q1 FY27 earnings call transcript reveals a record turnover exceeding ₹300 crore and per kg EBITDA reaching ₹46.7. The company is strategically shifting its revenue mix, with paints expected to contribute 40% in 3-4 years, driven by growth in Food & FMCG and Pharma. New product lines in ophthalmic and dosing pens are planned.
The announcement of record turnover, improved EBITDA margins, and strategic diversification into high-growth segments indicates a significant positive impact on the company's financial performance and future prospects.
The company reported a historical quarter with increased turnover and significant improvement in per kg EBITDA. Positive outlook on future growth segments and successful price pass-on strategies contribute to a positive sentiment.
Mold-Tek Packaging Limited has released the transcript of its Earnings Conference Call for Investors held on July 27, 2026, to discuss the company's Q1 FY27 results.
During the call, the Chairman and Managing Director, Mr. J. Lakshmana Rao, highlighted that the company achieved a historical quarter with turnover crossing ₹300 crore. A significant improvement was noted in per kg EBITDA, which rose to ₹46.7, historically around ₹40-42. This turnaround is attributed to increased sales in high value-add segments like pharma and food & FMCG, along with consolidation efforts, including reducing units in Hyderabad. The company successfully passed on raw material price hikes to clients and improved profit margins through internal efficiencies.
Discussions also covered the revenue mix, with paints expected to stabilize around 40% in the next 2-3 years due to faster growth in Food & FMCG and Qpack. Food & FMCG is projected to grow at 18-20% CAGR, while paints are expected to grow at 8-10% CAGR. The company added over 10-20 new clients in the Food & FMCG and pharma segments during the quarter.
Volume growth was impacted by a 17% drop in the lube segment due to base oil unavailability, affecting overall volume growth by approximately 3%. Despite this, the company is confident in sustaining EBITDA momentum and aims for ₹44-45 per kg for the full year. Future plans include expanding into ophthalmic products and dosing pens, with potential investments of ₹25-30 crore for new facilities. The company also anticipates capacity additions of 10-12% annually to capture growth and improve utilization.
What to do with a filing like this
Mold-Tek Packaging Limited filed this with the NSE as a statutory disclosure, categorised under concall transcript released. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Mold-Tek Packaging Limited. Read the original for the full detail.